Eri Nobusawa

2.4k total citations
58 papers, 1.8k citations indexed

About

Eri Nobusawa is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Eri Nobusawa has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 22 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Eri Nobusawa's work include Influenza Virus Research Studies (53 papers), Respiratory viral infections research (27 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Eri Nobusawa is often cited by papers focused on Influenza Virus Research Studies (53 papers), Respiratory viral infections research (27 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Eri Nobusawa collaborates with scholars based in Japan, United States and Taiwan. Eri Nobusawa's co-authors include K. Nakajima, Katsuhiko Sato, Yasuo Suzuki, Katsuhisa Nakajima, Yoshio Tateno, Setsuko Nakajima, Toru Aoyama, Takayuki Morishita, Hiroshi Ashihara and Hiroshi Ishihara and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

In The Last Decade

Eri Nobusawa

56 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eri Nobusawa Japan 19 1.4k 711 421 340 293 58 1.8k
Kanetsu Sugawara Japan 30 2.0k 1.4× 798 1.1× 599 1.4× 488 1.4× 231 0.8× 82 2.4k
Rodney S. Daniels United Kingdom 23 2.0k 1.4× 773 1.1× 484 1.1× 684 2.0× 490 1.7× 53 2.5k
Doris J. Bucher United States 24 1.3k 0.9× 475 0.7× 555 1.3× 398 1.2× 178 0.6× 55 1.8k
Robert G. Webster United States 15 1.3k 0.9× 400 0.6× 344 0.8× 517 1.5× 581 2.0× 16 1.7k
Delphine Guilligay France 15 1.3k 0.9× 1.3k 1.8× 547 1.3× 494 1.5× 184 0.6× 19 2.1k
Tatyana Matrosovich Germany 16 2.2k 1.5× 602 0.8× 747 1.8× 857 2.5× 455 1.6× 26 2.8k
Karthik Viswanathan United States 21 1.1k 0.7× 604 0.8× 363 0.9× 363 1.1× 330 1.1× 45 1.6k
Kiyoto Nakamura Japan 25 1.0k 0.7× 592 0.8× 318 0.8× 188 0.6× 88 0.3× 42 1.3k
Irene T. Schulze United States 19 944 0.7× 673 0.9× 233 0.6× 234 0.7× 110 0.4× 26 1.5k
Fumio Kitame Japan 25 907 0.6× 495 0.7× 327 0.8× 155 0.5× 85 0.3× 53 1.3k

Countries citing papers authored by Eri Nobusawa

Since Specialization
Citations

This map shows the geographic impact of Eri Nobusawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Nobusawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Nobusawa more than expected).

Fields of papers citing papers by Eri Nobusawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Nobusawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Nobusawa. The network helps show where Eri Nobusawa may publish in the future.

Co-authorship network of co-authors of Eri Nobusawa

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Nobusawa. A scholar is included among the top collaborators of Eri Nobusawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Nobusawa. Eri Nobusawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Hiroaki, et al.. (2023). Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective. Vaccine. 41(31). 4625–4631.
2.
Suzuki, Yasushi, Noriko Shimasaki, Hideki Hasegawa, et al.. (2023). Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields. PLoS ONE. 18(1). e0280811–e0280811.
3.
Takahashi, Hitoshi, Takao Fujimoto, Noriko Shimasaki, et al.. (2020). Determination of the potency of a cell-based seasonal quadrivalent influenza vaccine using a purified primary liquid standard. Biologicals. 68. 32–39. 3 indexed citations
4.
Itô, Hiroko, Hidekazu Nishimura, Oshi Watanabe, et al.. (2020). Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic. PLoS ONE. 15(5). e0233001–e0233001. 8 indexed citations
5.
Nithichanon, Arnone, Eri Nobusawa, Leonard Moise, et al.. (2017). A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines. Scientific Reports. 7(1). 1283–1283. 32 indexed citations
6.
Suzuki, Yasushi, Takato Odagiri, Masato Tashiro, & Eri Nobusawa. (2016). Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells. PLoS ONE. 11(7). e0160040–e0160040. 9 indexed citations
7.
Nakamura, Kazuya, Masayuki Shirakura, Yasushi Suzuki, et al.. (2015). Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain. Vaccine. 34(3). 328–333. 12 indexed citations
8.
Nobusawa, Eri, Katsumi Omagari, Setsuko Nakajima, & Katsuhisa Nakajima. (2012). Reactivity of human convalescent sera with influenza virus hemagglutinin protein mutants at antigenic site A. Microbiology and Immunology. 56(2). 99–106. 11 indexed citations
9.
Uchida, Yuko, Yasushi Suzuki, Masayuki Shirakura, et al.. (2012). Genetics and infectivity of H5N1 highly pathogenic avian influenza viruses isolated from chickens and wild birds in Japan during 2010–11. Virus Research. 170(1-2). 109–117. 22 indexed citations
10.
Fukuzawa, Kaori, Katsumi Omagari, Katsuhisa Nakajima, Eri Nobusawa, & Shigenori Tanaka. (2011). Sialic Acid Recognition of the Pandemic Influenza 2009 H1N1 Virus: Binding Mechanism Between Human Receptor and Influenza Hemagglutinin. Protein and Peptide Letters. 18(5). 530–539. 14 indexed citations
11.
Isaka, Masanori, Yanqiu Zhao, Eri Nobusawa, et al.. (2008). Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Microbiology and Immunology. 52(2). 55–63. 18 indexed citations
13.
Sato, Katsuhiko, Takayuki Morishita, Eri Nobusawa, et al.. (2000). Surveillance of influenza viruses isolated from travellers at Nagoya International Airport. Epidemiology and Infection. 124(3). 507–514. 17 indexed citations
14.
Nakajima, Setsuko, et al.. (1998). M protein correlates with the receptor-binding specificity of haemagglutinin protein of reassortant influenza A (H1N1) virus.. Journal of General Virology. 79(10). 2425–2434. 14 indexed citations
15.
Morishita, Takayuki, Eri Nobusawa, Sisi Luo, et al.. (1997). Analysis of the host-specific haemagglutination of influenza A(H1N1) viruses isolated in the 1995/6 season. Epidemiology and Infection. 119(3). 327–334. 2 indexed citations
16.
Nobusawa, Eri, Ryuichi Hishida, Masayuki Murata, et al.. (1995). The role of acidic residues in the ?fusion segment? of influenza A virus hemagglutinin in low-pH-dependent membrane fusion. Archives of Virology. 140(5). 865–875. 9 indexed citations
17.
Yamada, Akira, Eri Nobusawa, Mingshu Cao, et al.. (1991). Epitope Changes on the Haemagglutinin Molecule of Recently Isolated H1N1 Influenza Viruses. Journal of General Virology. 72(1). 97–102. 7 indexed citations
19.
Nakajima, Katsuhisa, Eri Nobusawa, & Setsuko Nakajima. (1990). Evolution of the NS genes of the influenza a viruses. II. Characteristics of the amino acid changes in the NS1 proteins of the influenza a viruses. Virus Genes. 4(1). 15–26. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026